APO Research
Talk to an analyst

APO RESEARCH · REPORT

PSA Test

Prostate-specific antigen (PSA), also known as gamma-seminoprotein or kallikrein-3 (KLK3), is a glycoprotein enzyme encoded in humans by the KLK3 gene.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Prostate-specific antigen (PSA), also known as gamma-seminoprotein or kallikrein-3 (KLK3), is a glycoprotein enzyme encoded in humans by the KLK3 gene.

The PSA test measures the level of PSA in a man’s blood. For this test, a blood sample is sent to a laboratory for analysis. The results are usually reported as nanograms of PSA per milliliter (ng/mL) of blood.

Selected research

Market Outlook & Growth Opportunities

Global PSA Test Market Outlook and Growth Opportunities 2026

2 January 2026192 pages

Choose your research edition.

Industry ResearchPSA Test Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal PSA Test Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal PSA Test Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal PSA Test Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal PSA Test Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

Prostate-specific antigen (PSA), also known as gamma-seminoprotein or kallikrein-3 (KLK3), is a glycoprotein enzyme encoded in humans by the KLK3 gene.

The PSA test measures the level of PSA in a man’s blood. For this test, a blood sample is sent to a laboratory for analysis. The results are usually reported as nanograms of PSA per milliliter (ng/mL) of blood.

The major players in global PSA Test market include Abbott, Siemens Healthcare, DiaSorin, etc. The top 3 players occupy about 50% shares of the global market. North America and Europe are main markets, they occupy over 80% of the global market. CLIA is the main type, with a share over 70%. Screening is the key application, which holds a share about 80%.

Read the full market overview

This report provides an overview of the global PSA Test market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of PSA Test and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents PSA Test sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the PSA Test market size, projected growth trends, production technologies, key applications, and end-use industries.

PSA Test Segment by Company

Abbott

Siemens Healthcare

DiaSorin

Roche

Beckman Coulter

PerkinElmer

Tosoh

Ortho Clinical

Fujirebio

Mediwatch

BodiTech

PSA Test Segment by Type

CLIA

ELISA

Others

PSA Test Segment by Application

Screening

Post-treatment Monitoring

Others

PSA Test Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global PSA Test status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions PSA Test market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify PSA Test significant trends, drivers, influence factors in global and regions.

6. To analyze PSA Test competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global PSA Test market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of PSA Test and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of PSA Test.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the PSA Test market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global PSA Test industry.

Chapter 3: Detailed analysis of PSA Test manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of PSA Test in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of PSA Test in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. PSA Test Industry Trends Table 2. PSA Test Industry Drivers Table 3. PSA Test Industry Opportunities and Challenges Table 4. PSA Test Industry Restraints Table 5. Global PSA Test Revenue by Company (US$ Million) & (2021-2026) Table 6. Global PSA Test Revenue Share by Company (2021-2026) Table 7. Global PSA Test Sales Volume by Company (K Units) & (2021-2026) Table 8. Global PSA Test Sales Volume Share by Company (2021-2026) Table 9. Global PSA Test Average Price (US$/Unit) of Company (2021-2026) Table 10. Global PSA Test Company Ranking, (2024-2026) & (USD Million) Table 11. Global PSA Test Key Company Manufacturing Base & Headquarters Table 12. Global PSA Test Company, Product Type & Application Table 13. Global PSA Test Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global PSA Test by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of CLIA Table 18. Significant Companies of ELISA Table 19. Significant Companies of Others Table 20. Global PSA Test Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 21. Global PSA Test Sales Volume by Type (2021-2026) & (K Units) Table 22. Global PSA Test Sales Volume by Type (2027-2032) & (K Units) Table 23. Global PSA Test Sales Volume Share by Type (2021-2026) Table 24. Global PSA Test Sales Volume Share by Type (2027-2032) Table 25. Global PSA Test Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global PSA Test Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global PSA Test Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global PSA Test Sales Value Share by Type (2021-2026) Table 29. Global PSA Test Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Screening Table 31. Significant Companies of Post-treatment Monitoring Table 32. Significant Companies of Others Table 33. Global PSA Test Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 34. Global PSA Test Sales Volume by Application (2021-2026) & (K Units) Table 35. Global PSA Test Sales Volume by Application (2027-2032) & (K Units) Table 36. Global PSA Test Sales Volume Share by Application (2021-2026) Table 37. Global PSA Test Sales Volume Share by Application (2027-2032) Table 38. Global PSA Test Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global PSA Test Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global PSA Test Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global PSA Test Sales Value Share by Application (2021-2026) Table 42. Global PSA Test Sales Value Share by Application (2027-2032) Table 43. Global PSA Test Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 44. Global PSA Test Sales by Region (2021-2026) & (K Units) Table 45. Global PSA Test Sales Market Share by Region (2021-2026) Table 46. Global PSA Test Sales by Region (2027-2032) & (K Units) Table 47. Global PSA Test Sales Market Share by Region (2027-2032) Table 48. Global PSA Test Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global PSA Test Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global PSA Test Sales Value Share by Region (2021-2026) Table 51. Global PSA Test Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global PSA Test Sales Value Share by Region (2027-2032) Table 53. Global PSA Test Market Average Price (US$/Unit) by Region (2021-2026) Table 54. Global PSA Test Market Average Price (US$/Unit) by Region (2027-2032) Table 55. Global PSA Test Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. Global PSA Test Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global PSA Test Sales by Country (2021-2026) & (K Units) Table 58. Global PSA Test Sales Market Share by Country (2021-2026) Table 59. Global PSA Test Sales by Country (2027-2032) & (K Units) Table 60. Global PSA Test Sales Market Share by Country (2027-2032) Table 61. Global PSA Test Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global PSA Test Sales Value Market Share by Country (2021-2026) Table 63. Global PSA Test Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global PSA Test Sales Value Market Share by Country (2027-2032) Table 65. Abbott Company Information Table 66. Abbott Business Overview Table 67. Abbott PSA Test Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 68. Abbott PSA Test Product Portfolio Table 69. Abbott Recent Development Table 70. Siemens Healthcare Company Information Table 71. Siemens Healthcare Business Overview Table 72. Siemens Healthcare PSA Test Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 73. Siemens Healthcare PSA Test Product Portfolio Table 74. Siemens Healthcare Recent Development Table 75. DiaSorin Company Information Table 76. DiaSorin Business Overview Table 77. DiaSorin PSA Test Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 78. DiaSorin PSA Test Product Portfolio Table 79. DiaSorin Recent Development Table 80. Roche Company Information Table 81. Roche Business Overview Table 82. Roche PSA Test Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 83. Roche PSA Test Product Portfolio Table 84. Roche Recent Development Table 85. Beckman Coulter Company Information Table 86. Beckman Coulter Business Overview Table 87. Beckman Coulter PSA Test Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 88. Beckman Coulter PSA Test Product Portfolio Table 89. Beckman Coulter Recent Development Table 90. PerkinElmer Company Information Table 91. PerkinElmer Business Overview Table 92. PerkinElmer PSA Test Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 93. PerkinElmer PSA Test Product Portfolio Table 94. PerkinElmer Recent Development Table 95. Tosoh Company Information Table 96. Tosoh Business Overview Table 97. Tosoh PSA Test Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 98. Tosoh PSA Test Product Portfolio Table 99. Tosoh Recent Development Table 100. Ortho Clinical Company Information Table 101. Ortho Clinical Business Overview Table 102. Ortho Clinical PSA Test Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 103. Ortho Clinical PSA Test Product Portfolio Table 104. Ortho Clinical Recent Development Table 105. Fujirebio Company Information Table 106. Fujirebio Business Overview Table 107. Fujirebio PSA Test Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 108. Fujirebio PSA Test Product Portfolio Table 109. Fujirebio Recent Development Table 110. Mediwatch Company Information Table 111. Mediwatch Business Overview Table 112. Mediwatch PSA Test Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 113. Mediwatch PSA Test Product Portfolio Table 114. Mediwatch Recent Development Table 115. BodiTech Company Information Table 116. BodiTech Business Overview Table 117. BodiTech PSA Test Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 118. BodiTech PSA Test Product Portfolio Table 119. BodiTech Recent Development Table 120. Key Raw Materials Table 121. Raw Materials Key Suppliers Table 122. PSA Test Distributors List Table 123. PSA Test Customers List Table 124. Research Programs/Design for This Report Table 125. Authors List of This Report Table 126. Secondary Sources Table 127. Primary Sources List of Figures Figure 1. PSA Test Product Image Figure 2. Global PSA Test Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global PSA Test Sales Value (2021-2032) & (US$ Million) Figure 4. Global PSA Test Sales (2021-2032) & (K Units) Figure 5. Global PSA Test Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global PSA Test Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. CLIA Image Figure 10. ELISA Image Figure 11. Others Image Figure 12. Global PSA Test Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 13. Global PSA Test Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global PSA Test Sales Volume Share by Type (2021-2032) Figure 15. Global PSA Test Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global PSA Test Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global PSA Test Sales Value Share by Type (2021-2032) Figure 18. Screening Image Figure 19. Post-treatment Monitoring Image Figure 20. Others Image Figure 21. Global PSA Test Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 22. Global PSA Test Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global PSA Test Sales Volume Share by Application (2021-2032) Figure 24. Global PSA Test Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global PSA Test Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global PSA Test Sales Value Share by Application (2021-2032) Figure 27. Global PSA Test Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 28. Global PSA Test Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global PSA Test Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global PSA Test Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America PSA Test Sales Value (2021-2032) & (US$ Million) Figure 32. North America PSA Test Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe PSA Test Sales Value (2021-2032) & (US$ Million) Figure 34. Europe PSA Test Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific PSA Test Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific PSA Test Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America PSA Test Sales Value (2021-2032) & (US$ Million) Figure 38. South America PSA Test Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa PSA Test Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa PSA Test Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA PSA Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA PSA Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA PSA Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada PSA Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada PSA Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada PSA Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico PSA Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico PSA Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico PSA Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany PSA Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany PSA Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany PSA Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France PSA Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France PSA Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France PSA Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. PSA Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. PSA Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. PSA Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy PSA Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy PSA Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy PSA Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain PSA Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain PSA Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain PSA Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia PSA Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia PSA Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia PSA Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands PSA Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands PSA Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands PSA Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries PSA Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries PSA Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries PSA Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China PSA Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China PSA Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China PSA Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan PSA Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan PSA Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan PSA Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea PSA Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea PSA Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea PSA Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India PSA Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India PSA Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India PSA Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia PSA Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia PSA Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia PSA Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia PSA Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia PSA Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia PSA Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil PSA Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil PSA Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil PSA Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina PSA Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina PSA Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina PSA Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile PSA Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile PSA Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile PSA Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia PSA Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia PSA Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia PSA Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru PSA Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru PSA Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru PSA Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia PSA Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia PSA Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia PSA Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel PSA Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia PSA Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia PSA Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE PSA Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE PSA Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE PSA Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey PSA Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey PSA Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey PSA Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran PSA Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran PSA Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran PSA Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt PSA Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt PSA Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt PSA Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. PSA Test Value Chain Figure 126. Manufacturing Cost Structure Figure 127. PSA Test Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • CLIA
  • ELISA
  • Others
Applications
  • Screening
  • Post-treatment Monitoring
  • Others
Companies covered
  • Abbott
  • Siemens Healthcare
  • DiaSorin
  • Roche
  • Beckman Coulter
  • PerkinElmer
  • Tosoh
  • Ortho Clinical
  • Fujirebio
  • Mediwatch
  • BodiTech

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global PSA Test Sales Value (2021-2032)
  4. 1.2.2 Global PSA Test Sales Volume (2021-2032)
  5. 1.2.3 Global PSA Test Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 PSA Test Market Dynamics
  1. 2.1 PSA Test Industry Trends
  2. 2.2 PSA Test Industry Drivers
  3. 2.3 PSA Test Industry Opportunities and Challenges
  4. 2.4 PSA Test Industry Restraints
3 PSA Test Market by Company
  1. 3.1 Global PSA Test Company Revenue Ranking in 2025
  2. 3.2 Global PSA Test Revenue by Company (2021-2026)
  3. 3.3 Global PSA Test Sales Volume by Company (2021-2026)
  4. 3.4 Global PSA Test Average Price by Company (2021-2026)
  5. 3.5 Global PSA Test Company Ranking (2024-2026)
  6. 3.6 Global PSA Test Company Manufacturing Base and Headquarters
  7. 3.7 Global PSA Test Company Product Type and Application
  8. 3.8 Global PSA Test Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global PSA Test Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 PSA Test Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 PSA Test Market by Type
  1. 4.1 PSA Test Type Introduction
  2. 4.1.1 CLIA
  3. 4.1.2 ELISA
  4. 4.1.3 Others
  5. 4.2 Global PSA Test Sales Volume by Type
  6. 4.2.1 Global PSA Test Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global PSA Test Sales Volume by Type (2021-2032)
  8. 4.2.3 Global PSA Test Sales Volume Share by Type (2021-2032)
  9. 4.3 Global PSA Test Sales Value by Type
  10. 4.3.1 Global PSA Test Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global PSA Test Sales Value by Type (2021-2032)
  12. 4.3.3 Global PSA Test Sales Value Share by Type (2021-2032)
5 PSA Test Market by Application
  1. 5.1 PSA Test Application Introduction
  2. 5.1.1 Screening
  3. 5.1.2 Post-treatment Monitoring
  4. 5.1.3 Others
  5. 5.2 Global PSA Test Sales Volume by Application
  6. 5.2.1 Global PSA Test Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global PSA Test Sales Volume by Application (2021-2032)
  8. 5.2.3 Global PSA Test Sales Volume Share by Application (2021-2032)
  9. 5.3 Global PSA Test Sales Value by Application
  10. 5.3.1 Global PSA Test Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global PSA Test Sales Value by Application (2021-2032)
  12. 5.3.3 Global PSA Test Sales Value Share by Application (2021-2032)
6 PSA Test Regional Sales and Value Analysis
  1. 6.1 Global PSA Test Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global PSA Test Sales by Region (2021-2032)
  3. 6.2.1 Global PSA Test Sales by Region: 2021-2026
  4. 6.2.2 Global PSA Test Sales by Region (2027-2032)
  5. 6.3 Global PSA Test Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global PSA Test Sales Value by Region (2021-2032)
  7. 6.4.1 Global PSA Test Sales Value by Region: 2021-2026
  8. 6.4.2 Global PSA Test Sales Value by Region (2027-2032)
  9. 6.5 Global PSA Test Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America PSA Test Sales Value (2021-2032)
  12. 6.6.2 North America PSA Test Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe PSA Test Sales Value (2021-2032)
  15. 6.7.2 Europe PSA Test Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific PSA Test Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific PSA Test Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America PSA Test Sales Value (2021-2032)
  21. 6.9.2 South America PSA Test Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa PSA Test Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa PSA Test Sales Value Share by Country, 2025 VS 2032
7 PSA Test Country-level Sales and Value Analysis
  1. 7.1 Global PSA Test Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global PSA Test Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global PSA Test Sales by Country (2021-2032)
  4. 7.3.1 Global PSA Test Sales by Country (2021-2026)
  5. 7.3.2 Global PSA Test Sales by Country (2027-2032)
  6. 7.4 Global PSA Test Sales Value by Country (2021-2032)
  7. 7.4.1 Global PSA Test Sales Value by Country (2021-2026)
  8. 7.4.2 Global PSA Test Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA PSA Test Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA PSA Test Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA PSA Test Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada PSA Test Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada PSA Test Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada PSA Test Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico PSA Test Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico PSA Test Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico PSA Test Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany PSA Test Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany PSA Test Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany PSA Test Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France PSA Test Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France PSA Test Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France PSA Test Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. PSA Test Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. PSA Test Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. PSA Test Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy PSA Test Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy PSA Test Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy PSA Test Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain PSA Test Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain PSA Test Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain PSA Test Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia PSA Test Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia PSA Test Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia PSA Test Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands PSA Test Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands PSA Test Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands PSA Test Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries PSA Test Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries PSA Test Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries PSA Test Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China PSA Test Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China PSA Test Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China PSA Test Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan PSA Test Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan PSA Test Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan PSA Test Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea PSA Test Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea PSA Test Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea PSA Test Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India PSA Test Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India PSA Test Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India PSA Test Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia PSA Test Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia PSA Test Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia PSA Test Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia PSA Test Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia PSA Test Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia PSA Test Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil PSA Test Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil PSA Test Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil PSA Test Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina PSA Test Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina PSA Test Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina PSA Test Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile PSA Test Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile PSA Test Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile PSA Test Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia PSA Test Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia PSA Test Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia PSA Test Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru PSA Test Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru PSA Test Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru PSA Test Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia PSA Test Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia PSA Test Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia PSA Test Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel PSA Test Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel PSA Test Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel PSA Test Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE PSA Test Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE PSA Test Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE PSA Test Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey PSA Test Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey PSA Test Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey PSA Test Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran PSA Test Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran PSA Test Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran PSA Test Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt PSA Test Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt PSA Test Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt PSA Test Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Abbott
  2. 8.1.1 Abbott Company Information
  3. 8.1.2 Abbott Business Overview
  4. 8.1.3 Abbott PSA Test Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Abbott PSA Test Product Portfolio
  6. 8.1.5 Abbott Recent Developments
  7. 8.2 Siemens Healthcare
  8. 8.2.1 Siemens Healthcare Company Information
  9. 8.2.2 Siemens Healthcare Business Overview
  10. 8.2.3 Siemens Healthcare PSA Test Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Siemens Healthcare PSA Test Product Portfolio
  12. 8.2.5 Siemens Healthcare Recent Developments
  13. 8.3 DiaSorin
  14. 8.3.1 DiaSorin Company Information
  15. 8.3.2 DiaSorin Business Overview
  16. 8.3.3 DiaSorin PSA Test Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 DiaSorin PSA Test Product Portfolio
  18. 8.3.5 DiaSorin Recent Developments
  19. 8.4 Roche
  20. 8.4.1 Roche Company Information
  21. 8.4.2 Roche Business Overview
  22. 8.4.3 Roche PSA Test Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Roche PSA Test Product Portfolio
  24. 8.4.5 Roche Recent Developments
  25. 8.5 Beckman Coulter
  26. 8.5.1 Beckman Coulter Company Information
  27. 8.5.2 Beckman Coulter Business Overview
  28. 8.5.3 Beckman Coulter PSA Test Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Beckman Coulter PSA Test Product Portfolio
  30. 8.5.5 Beckman Coulter Recent Developments
  31. 8.6 PerkinElmer
  32. 8.6.1 PerkinElmer Company Information
  33. 8.6.2 PerkinElmer Business Overview
  34. 8.6.3 PerkinElmer PSA Test Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 PerkinElmer PSA Test Product Portfolio
  36. 8.6.5 PerkinElmer Recent Developments
  37. 8.7 Tosoh
  38. 8.7.1 Tosoh Company Information
  39. 8.7.2 Tosoh Business Overview
  40. 8.7.3 Tosoh PSA Test Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Tosoh PSA Test Product Portfolio
  42. 8.7.5 Tosoh Recent Developments
  43. 8.8 Ortho Clinical
  44. 8.8.1 Ortho Clinical Company Information
  45. 8.8.2 Ortho Clinical Business Overview
  46. 8.8.3 Ortho Clinical PSA Test Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Ortho Clinical PSA Test Product Portfolio
  48. 8.8.5 Ortho Clinical Recent Developments
  49. 8.9 Fujirebio
  50. 8.9.1 Fujirebio Company Information
  51. 8.9.2 Fujirebio Business Overview
  52. 8.9.3 Fujirebio PSA Test Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Fujirebio PSA Test Product Portfolio
  54. 8.9.5 Fujirebio Recent Developments
  55. 8.10 Mediwatch
  56. 8.10.1 Mediwatch Company Information
  57. 8.10.2 Mediwatch Business Overview
  58. 8.10.3 Mediwatch PSA Test Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Mediwatch PSA Test Product Portfolio
  60. 8.10.5 Mediwatch Recent Developments
  61. 8.11 BodiTech
  62. 8.11.1 BodiTech Company Information
  63. 8.11.2 BodiTech Business Overview
  64. 8.11.3 BodiTech PSA Test Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 BodiTech PSA Test Product Portfolio
  66. 8.11.5 BodiTech Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 PSA Test Value Chain Analysis
  2. 9.1.1 PSA Test Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 PSA Test Sales Mode & Process
  6. 9.2 PSA Test Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 PSA Test Distributors
  9. 9.2.3 PSA Test Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst